{"sourcedb":"DevicePMAs@therightstef","sourceid":"P040005_S000","text":"Approval for the dakocytomation her2 fish pharmdx kit.  The device is indicated for:  the dakocytomation her2 fish pharmdx kit is a direct fluorescence in situ  hybridization (fish) assay designed to quantitatively determine the her2 gene amplification in formalin-fixed, paraffin-embedded breast cancer tissue specimens.  Her2 fish pharmdx kit is indicated as an aid in the assessment of patients for whom herceptin (trastuzumab) treatment is being considered.  Results form the her2 fish pharmdx kit are intended for use as an adjunct to the clinicopathologic information currently used for estimating prognosis in stage ii, node positive breast cancer patients.","project":"consensus_PMA_Age_Indications"}